RichardCyrusEastmanMD

PubMed

• 74 citations
  Drug-resistant malaria: molecular mechanisms and implications for public health.
  Petersen, I., Eastman, R. C., Lanzer, M.> ;FEBS letters. 2011 May 3
• Home use of the GlucoWatch G2 biographer in children with diabetes.
  Eba Hathout, Nina Patel, Christina Southern, Julie Hill, Reginald Anderson, Jeannine Sharkey, Merrilee Hadley-Scofield, Long Tran, Amy D. Leptien, Margarita Lopatin, B...> ;Pediatrics. 2005 Mar 1
• Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus
  Frederick B. Dong, Stephen W. Sorensen, Diane L. Manninen, Theodore J. Thompson, Venkat Narayan, Carlyn E. Orians, Edward W. Gregg, Richard C. Eastman, Erik J. Dasbach...> ;PharmacoEconomics. 2004 Jan 1
• Use of the Cygnus GlucoWatch Biographer at a Diabetes Camp
  Laura M. Gandrud, Helen U. Paguntalan, Michelle Van Wyhe, Betsy Kunselman, Amy D. Leptien, Darrell M. Wilson, Richard C. Eastman, Bruce A. Buckingham> ;Pediatrics. 2004 Jan 1
• Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial.
  Eastman, R. C., Leptien, A. D., Chase, H. P.> ;Pediatric diabetes. 2003 Dec 6
• Use of the GlucoWatch Biographer in Children With Type 1 Diabetes
  H. Peter Chase, Mary D. Roberts, Clare Wightman, Georgeanna J. Klingensmith, Satish K. Garg, Michelle Van Wyhe, Shashi Desai, Wesley S. Harper, Margarita Lopatin, Miro...> ;Pediatrics. 2003 Apr 1
• 1 citation
  How should we interpret "real life" conditions.
  Richard C. Eastman, H. Peter Chase, Bruce A. Buckingham, Eba Hathout, Janet Tamada, Barry H. Ginsberg> ;Pediatric Diabetes. 2003 Mar 1
• Implications of the United kingdom prospective diabetes study.
  Saul Genuth, Richard C. Eastman, Richard Kahn, Ronald Klein, John M. Lachin, Harold E. Lebovitz, David M. Nathan, Frank Vinicor> ;Diabetes Care. 2003 Jan 1
• Use of the GlucoWatch biographer in children and adolescents with diabetes.
  Richard C. Eastman, H. Peter Chase, Bruce A. Buckingham, Eba Hathout, Lee Fuller-Byk, Amy D. Leptien, Michelle Van Wyhe, Tara L. Davis, Steven J. Fermi, Henk Pechler, ...> ;Pediatric Diabetes. 2002 Sep 1
• The GlucoWatch biographer: a frequent automatic and noninvasive glucose monitor.
  Michael J. Tierney, Janet Tamada, Russell O. Potts, Richard C. Eastman, Kenneth R. Pitzer, Neil R. Ackerman, Steven J. Fermi> ;Annals of Medicine. 2000 Dec 1
• Racial and ethnic differences in glycemic control of adults with type 2 diabetes.
  Maureen I Harris, Richard C. Eastman, Catherine C. Cowie, Katherine M. Flegal, Mark S. Eberhardt> ;Diabetes Care. 1999 Mar 1
• The Effects of Treatment on the Direct Costs of Diabetes
  William H. Herman, Richard C. Eastman> ;Diabetes Care. 1998 Dec 1
• Is there a glycemic threshold for mortality risk
  Maureen I Harris, Richard C. Eastman> ;Diabetes Care. 1998 Mar 1
• Cost-Effectiveness of Treatment of Type 2 Diabetes
  Richard C. Eastman> ;Diabetes Care. 1998 Mar 1
• Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnos...
  Maureen I Harris, Richard C. Eastman, Catherine C. Cowie, Katherine M. Flegal, Mark S. Eberhardt> ;Diabetes Care. 1997 Dec 1
• Is intensive glycemic control worth the expense
  Richard C. Eastman> ;Cleveland Clinic Journal of Medicine. 1997 Sep 1
• The cost-effectiveness of intensive therapy for diabetes mellitus
  William H. Herman, Erik J. Dasbach, Thomas J. Songer, Richard C. Eastman> ;Endocrinology and Metabolism Clinics of North America. 1997 Sep 1
• Science: moving us in the right direction.
  Richard C. Eastman, Frank Vinicor> ;Diabetes Care. 1997 Jul 1
• Model of Complications of NIDDM: I. Model construction and assumptions
  Richard C. Eastman, Jonathan C. Javitt, William H. Herman, Erik J. Dasbach, Arthur S. Zbrozek, Fred Dong, Diane L. Manninen, Sanford A. Garfield, Catherine Copley-Merr...> ;Diabetes Care. 1997 May 1
• Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia
  Richard C. Eastman, Jonathan C. Javitt, William H. Herman, Erik J. Dasbach, Catherine Copley-Merriman, William Maier, Fred Dong, Diane L. Manninen, Arthur S. Zbrozek, ...> ;Diabetes Care. 1997 May 1
• Undiagnosed Diabetes or Impaired Glucose Tolerance and Cardiovascular Risk
  Richard C. Eastman, Catherine C. Cowie, Maureen I Harris> ;Diabetes Care. 1997 Feb 1
• Non-Insulin-Mediated Glucose Disappearance in Subjects With IDDM: Discordance Between Experimental Results and Minimal Model Analysis
  Michael J. Quon, Craig Cochran, Simenon I Taylor, Richard C. Eastman> ;Diabetes. 1994 Jul 1
• The DCCT and medical care for diabetes in the U.S.
  Maureen I Harris, Richard C. Eastman, Carolyn Siebert> ;Diabetes Care. 1994 Jul 1
• Clinical review 51: Implications of the Diabetes Control and Complications Trial.
  Richard C. Eastman, Carolyn Siebert, Maureen I Harris, Phillip Gorden> ;The Journal of Clinical Endocrinology and Metabolism. 1993 Nov 1
• Lessening the Burden of Diabetes: Intervention Strategies
  Richard C. Eastman, Robert Silverman, Maureen I Harris, Jonathan C. Javitt, Yen Pin Chiang, Phillip Gorden> ;Diabetes Care. 1993 Aug 1
• Join now to see all